BlueLinx Holdings Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BlueLinx Holdings Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,881	1,816	2,863	2,637	3,097	4,277	4,450	3,136	2,953	2,954
Cost of revenue	1,654	1,585	2,531	2,280	2,620	3,499	3,617	2,609	2,463	2,502
Gross profit	227	231	332	357	478	778	833	527	489	452
Selling, general and administrative	205	199	319	292	314	322	366	356	366	381
Operating expenses	186	201	345	322	335	340	394	389	402	419
Operating income	41.7	30	-13.3	35.2	142	438	439	138	87.6	32.5
Interest expense	24.9	21.2	47.3	54.2	47.4	45.5	42.3	23.7	47.2	49.7
Interest income							3.23	20.9	27.8	17.3
Other non-operating income	0.45	0.82	0.38	-2.54	0.25	1.31	-2.05	-2.38	0	0
Pre-tax income	17.2	9.59	-60.2	-21.6	95.1	394	395	81.9	70.7	0.13
Income tax	1.12	-53.4	-12.2	-3.95	14.2	97.7	98.6	33.4	17.6	-0.09
Net income	16.1	63	-17.7	-17.7	80.9	296	296	48.5	53.1	0.22
EBITDA	51	39	12.5	65.4	171	466	467	170	126	72.4
EPS, basic	1.80	6.96	-5.21	-1.89	8.58	30.80	31.75	5.40	6.22	0.02
EPS, diluted	1.77	6.81	-5.21	-1.89	8.55	29.99	31.51	5.39	6.19	0.02
Shares, basic (weighted)	8.91	9.05	9.23	9.36	9.42	9.62	9.33	8.99	8.53	7.98
Shares, diluted (weighted)	9.07	9.25	9.23	9.36	9.46	9.88	9.4	8.99	8.57	8.04

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	5.54	4.7	8.94	11.6	0.08	85.2	299	522	506	386
Receivables	126	134	208	193	294	340	252	228	226	218
Inventory	191	188	342	346	342	488	484	344	356	326
Other current assets	23.1	17.1	40.6	27.7	32.6	31.9	42.1	26.6	46.6	54.5
Total current assets	346	343	600	578	668	945	1,077	1,120	1,134	984
Property, plant and equipment	88.3	83.8	205	196	179	181	206	226	250	287
Lease right-of-use assets			0	54.4	51.1	49.6	45.7	37.2	47.2	54.6
Goodwill		0	47.8	47.8	47.8	47.8	55.4	55.4	55.4	67.2
Intangible assets		0	35.2	26.4	18.9	13.6	35	30.8	26.9	86.7
Other non-current assets	10	13.1	19.3	15.1	20.3	19.9	15.3	14.6	14.1	18.9
Total assets	444	494	960	971	1,048	1,317	1,490	1,538	1,578	1,549
Accounts payable	82.7	70.6	149	132	165	180	152	158	170	136
Accrued liabilities	8.35	9.23	7.97	7.64	24.8	22.4
Short-term debt	29.5	0	1.74	2.18	1.17	0	7.09	11.2	12.5
Total current liabilities	154	118	197	171	229	244	211	219	234	211
Long-term debt	271	277	498	458	321	291	292	294	295	297
Lease liabilities			0	47.1	45	44.5	40	32.5	40.1	47.1
Other non-current liabilities	14.5	9.96	23.7	24	25.6	22	20.5	17.6	19.1	18.7
Total liabilities	474	459	975	998	989	954	900	903	931	932
Total debt	300	277	500	461	322	291	292	294	295	297
Paid-in capital	258	260	259	261	267	268	201	165	124	94.8
Retained earnings	-251	-188	-236	-253	-172	124	421	469	522	522
Other comprehensive income	-36.7	-36.5	-37.1	-34.6	-36	-29.4	-31.4	0
Shareholders' equity	-29.8	35	-14.7	-26.1	59.1	363	590	634	646	617
Total equity	-29.8	35	-14.7	-26.1	59.1	363	590	634	646	617
Total liabilities and equity	444	494	960	971	1,048	1,317	1,490	1,538	1,578	1,549
Shares outstanding	9.03	9.1	9.29	9.37	9.46	9.73	9.05	8.65	8.65	7.87

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	16.1	63	-17.7	-17.7	80.9	296	296	48.5	53.1	0.22
Depreciation and amortization	9.34	9.03	25.8	30.2	28.9	28.2	27.6	32	38.5	39.9
Stock-based compensation	2.34	2.48	8.47	2.59	5.99	6.59	9.62	12.1	7.75	11.3
Deferred income tax					-8.42	0.36	5.29	7.76	2.68	-0.04
Change in receivables	12.7	-8.21	60	15.6	-101	-46	101	23.1	2.57	14.1
Change in inventory	35.4	3.78	4.89	-3.96	3.7	-146	20.8	141	-12.3	46
Change in payables	-5.35	-12.1	25	-16.8	32.8	14.8	-31.8	5.97	13	-36
Cash from operations	41.4	-2.5	41.6	-10.3	55	145	400	306	85.2	59.8
Capital expenditures	-0.63	-0.8	-2.72	-4.79	-3.69	-14.4	-35.9	-27.5	-40.1	-26.9
Acquisitions	0	0	-348	6.01	0	0	-63.8	0.3	0	-95.2
Cash from investing	36.8	26.8	-243	21.1	9.16	-4.09	-98.7	-26.9	-39.2	-119
Debt issued	0	0	180	0
Debt repaid	0	0	-0.9	-32.4	-103	-43.2	0	0
Share buybacks					0	0	-66.4	-42.1	-45.3	-38.1
Cash from financing	-77.5	-25.2	205	-8.14	-75.7	-55.8	-87.9	-56.6	-62.1	-60.1
Net change in cash	0.73	-0.84	4.24	2.7	-11.6	85.1	214	223	-16.1	-120
Free cash flow	40.8	-3.3	38.8	-15.1	51.3	131	364	279	45.1	32.9
Interest paid	21.2	19.8	37.3	47.3	43.5	33.2	44.1	43.4	45	47.1
Income taxes paid	0.63	1.58	2.64	2.99	14.4	98.9	111	19.2	30.4	3.99

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $76.35 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	15.8%	Gross profit / revenue.
Operating margin	1.2%	Operating income / revenue.
EBITDA margin	2.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-0.0%	Pre-tax income / revenue.
Net margin	-0.1%	Net income / revenue.
FCF margin	1.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	2.5%	Cash from operations / revenue.
Return on equity (ROE)	-0.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-0.1%	Net income / average total assets.
Return on invested capital (ROIC)	4.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	13.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.5%	Capital expenditures / revenue.
D&A / revenue	1.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	0.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-12.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-0.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-7.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-18.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-1.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-62.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-58.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-25.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-42.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-46.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-15.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-99.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-91.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-69.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-99.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-91.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-70.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-29.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-46.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	1.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-27.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-55.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-8.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-4.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	1.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	59.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	1.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-6.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-5.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-3.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.01x	Current assets / current liabilities.
Quick ratio	2.39x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.20x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.48x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	18.5%	Total debt / total assets.
Liabilities / assets	61.2%	Total liabilities / total assets.
Net debt	-$21.1M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.27x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.70x	Operating income / interest expense.
Working capital	$796.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	9.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$472.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.88x	Revenue / average total assets.
Fixed asset turnover	10.9x	Revenue / average property, plant and equipment.
Inventory turnover	6.75x	Cost of revenue / average inventory.
Days inventory	54 days	365 x average inventory / cost of revenue.
Receivables turnover	9.53x	Revenue / average receivables.
Days sales outstanding	38 days	365 x average receivables / revenue.
Days payables	27 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	65 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	22.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.25	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$382.98	Revenue / diluted weighted shares.
FCF per share	$7.38	Free cash flow / diluted weighted shares.
Operating cash flow per share	$9.47	Cash from operations / diluted weighted shares.
Book value per share	$79.07	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$60.08	Tangible book value / shares outstanding.
Cash per share	$40.48	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	13.9%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$600.1M	Share price x shares outstanding.
Enterprise value	$579.0M	Market cap + total debt - cash - short-term investments.
P/S	0.20x	Market cap / revenue.
P/B	0.97x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.27x	Market cap / tangible book value, when positive.
P/FCF	10.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.07x	Market cap / cash from operations, when positive.
EV/Sales	0.19x	Enterprise value / revenue.
EV/EBIT	16.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.36x	Enterprise value / EBITDA, when both are positive.
EV/FCF	9.98x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.7%	Free cash flow / market cap.
Earnings yield	-0.3%	Net income / market cap (the inverse of P/E).
Shareholder yield	1.3%	(Dividends paid + share buybacks) / market cap.

What was BlueLinx Holdings Inc.'s revenue in fiscal 2025?

BlueLinx Holdings Inc. reported revenue of $2.95B for fiscal 2025, 0% higher than the year before.

Was BlueLinx Holdings Inc. profitable in fiscal 2025?

Yes. Net income was $219.0K, a net margin of 0%.

How much free cash flow did BlueLinx Holdings Inc. generate in fiscal 2025?

Cash from operations of $59.8M minus capital expenditures of $26.9M left free cash flow of $32.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BlueLinx Holdings Inc.